Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial A total of 68,463 eligible patients underwent curative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results